On Wednesday, Capricor Therapeutics Inc (CAPR) stock saw a modest uptick, ending the day at $21.39 which represents a slight increase of $1.25 or 6.21% from the prior close of $20.14. The stock opened ...

Deep-pocketed investors have adopted a bearish approach towards Capricor Therapeutics CAPR, and it's something market players ...

Equities research analysts at Piper Sandler assumed coverage on shares of Capricor Therapeutics (NASDAQ:CAPR – Get Free Report) in a note issued to investors on Monday, Ratings reports. The firm set ...

Capricor Therapeutics (NASDAQ:CAPR) filed to sell 2.8M shares of common stock for holders. This prospectus is not an offer to sell. Filing More on Capricor Therapeutics Capricor: DMD Treatment Focus ...

Fintel reports that on October 21, 2024, Piper Sandler initiated coverage of Capricor Therapeutics (NasdaqCM:CAPR) with a ...

On Friday, Capricor Therapeutics Inc (CAPR) stock saw a modest uptick, ending the day at $18.86 which represents a slight increase of $0.37 or 2.00% from the prior close of $18.49. The stock opened at ...

Edward Tenthoff, an analyst from Piper Sandler, has initiated a new Buy rating on Capricor Therapeutics (CAPR). Edward Tenthoff’s rating ...

Capricor Therapeutics shares are trading lower by 2.7% during Thursday's session. The company earlier commenced its public ...

Shares of Capricor Therapeutics fell more than 10% in premarket trading Thursday after the biotechnology company said it is raising about $75 million in a public stock offering. The San Diego company ...

Kinder Morgan (NYSE: KMI) fell 1.6% after it published third quarter results, with revenue and operating profit trailing ...

Oppenheimer analyst Leland Gershell maintained a Buy rating on Capricor Therapeutics (CAPR – Research Report) today and set a price ...

Capricor (CAPR) stock rose 5% after the company reported long-term data from a study of its drug deramiocel in the treatment ...